Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Evolent HealthEVH +0.22%64 3-Year Share Buyback Ratio is -3.70 as of Jun. 2026. GuruFocus rates EVH with a GF Score™ of 64/100 and a GF Value™ of $10.17 (Possible Value Trap). The stock has 7 warning signs investors should review. Among 447 Healthcare Providers & Services companies, Evolent Health ranks worse than 61.07% on this metric.
Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.
3-Year Share Buyback Ratio measures the average annual proportion of a company's outstanding shares repurchased over the past three years. It is calculated as the annualized percentage change in shares outstanding from three years ago to the current year. A positive ratio may indicate share buybacks over the period, while a zero or negative ratio may reflect no repurchases or potential share issuance. Evolent Health's current 3-Year Share Buyback Ratio was -3.70%.
The historical rank and industry rank for Evolent Health's 3-Year Share Buyback Ratio or its related term are showing as below:
EVH'
s 3-Year Share Buyback Ratio Range Over the Past 10 Years
Min: -25 Med: -9.65 Max: -3.7
Current: -3.7
During the past 13 years, Evolent Health's highest 3-Year Share Buyback Ratio was -3.70%. The lowest was -25.00%. And the median was -9.65%.
EVH's 3-Year Share Buyback Ratio is ranked worse than 61.07% of 447
companies
in the Healthcare Providers & Services industry
Industry Median: -1.7
vs EVH: -3.70
Evolent Health (NYSE:EVH) 3-Year Share Buyback Ratio Explanation
A negative number means the company might be issuing new shares. A positive number indicates that the company is buying back shares.
Be Aware
Investors usually like share buybacks. But as pointed by Warren Buffett, only if a company buys back shares at the prices below the stock's intrinsic value, it rewards remaining shareholders. If a company buys its overvalued stocks back, it destroys shareholder value.
Evolent Health 3-Year Share Buyback Ratio Related Terms
EVH vs NRC, SOPH, WEAV: 3-Year Share Buyback Ratio Comparison
For the Health Information Services subindustry, Evolent Health's 3-Year Share Buyback Ratio, along with its competitors' market caps and 3-Year Share Buyback Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Evolent Health 3-Year Share Buyback Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Evolent Health's 3-Year Share Buyback Ratio distribution charts can be found below:
* The bar in red indicates where Evolent Health's 3-Year Share Buyback Ratio falls into.
Evolent Health 3-Year Share Buyback Ratio Calculation
This is the annualized percentage change in shares outstanding from three years ago to the current year. The annualized percentage change is calculated with expontential compound based on the latest four years of annual data on Shares Outstanding (EOP).
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.
What does a 3-Year Share Buyback Ratio of -3.70 mean?
Evolent Health (EVH) has a 3-Year Share Buyback Ratio of -3.70 as of Jun. 2026. The 3-Year Share Buyback Ratio measures the average annual proportion of a company's outstanding shares repurchased over the past three years. It is calculated as the annualized percentage change in shares outstanding from three years ago to the current year. View historical data for Evolent Health and its competitors. According to the industry distribution chart, Evolent Health ranks #273 out of 447 companies in the Healthcare Providers & Services industry, placing it in the top 61.1%.
Is Evolent Health's 3-Year Share Buyback Ratio too high?
Evolent Health's current 3-Year Share Buyback Ratio is -3.70. Based on the distribution chart, Evolent Health ranks #273 out of 447 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Evolent Health has a GF Score™ of 64/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Evolent Health's 3-Year Share Buyback Ratio compare to NRC and SOPH?
According to the Healthcare Providers & Services industry distribution chart, Evolent Health ranks #273 out of 447 companies for 3-Year Share Buyback Ratio. This places Evolent Health in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year Share Buyback Ratio for a Healthcare Providers & Services company?
A good 3-Year Share Buyback Ratio depends on the Healthcare Providers & Services industry context. However, 3-Year Share Buyback Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year Share Buyback Ratio mean?
A high 3-Year Share Buyback Ratio can signal that a stock is expensive relative to its fundamentals. The 3-Year Share Buyback Ratio measures the average annual proportion of a company's outstanding shares repurchased over the past three years. It is calculated as the annualized percentage change in shares outstanding from three years ago to the current year. View historical data for Evolent Health and its competitors. Evolent Health's current 3-Year Share Buyback Ratio is -3.70. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Evolent Health stock overvalued right now?
Based on GuruFocus' analysis, Evolent Health (EVH) is currently considered Possible Value Trap. The stock's GF Value™ is $10.17, compared to a current price of $4.60 — trading 54.8% below its estimated fair value. The current 3-Year Share Buyback Ratio is -3.70. Evolent Health's overall GF Score™ is 64/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year Share Buyback Ratio calculated?
3-Year Share Buyback Ratio is calculated from a company's financial statements. For Evolent Health (EVH), the current 3-Year Share Buyback Ratio is -3.70 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Evolent Health (EVH) Overvalued in 2026?
Based on GuruFocus' analysis, Evolent Health stock appears to be undervalued.
The current stock price of $4.60 is trading 54.8% below its estimated GF Value™ of $10.17.
GuruFocus considers Evolent Health to be Possible Value Trap.
Key valuation signals for EVH:
3-Year Share Buyback Ratio: -3.70
GF Value™: $10.17 vs. price of $4.60 (54.8% below fair value)
No single metric tells the full story. See the EVH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Evolent Health Inc is engaged in healthcare delivery and payment. The company supports health systems and physician organizations in their migration toward value-based care and population health management. It provides specialty care management services in oncology, cardiology, musculoskeletal markets and holistic total cost of care management along with an integrated platform for health plan administration and value-based business infrastructure under one go to market package. The solutions provided by the company includes: Oncology, Cardiology, Musculoskeletal, Administrative Services, Advanced Illness, Genetic Testing, Physical Medicine, Radiology, and Surgical Management.
64GF Score
Get the complete analysis for EVH
3-Year Share Buyback Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
EVH has been successfully added to your 
